第一個晚期甲狀腺癌治療諾華Tafinlar加Mekinist合併療法過關 ... | 合法藥品大搜索

2019年4月28日 — 【癌症標靶用藥衛教諮詢】 學名: Mekinist 2mg/Tab 中文品名:麥欣霓膜衣錠2毫克商品名:Trametinib 適應症: 1. 黑色素瘤: Trametinib 單一療法或 ... Read More

Mekinist is a cancer medicine used to treat adults whose cancer cells have a specific genetic mutation (change) in their genes called 'BRAF V600'. Read More

英文品名, Mekinist Film-Coated Tablets 2mg. 適應症, 1. 黑色素瘤: Trametinib 單一療法或與dabrafenib 併用，可用於治療罹患發生BRAF V600突變且無法切除或有轉移 ... Read More

Withhold MEKINIST for a temperature of ˃104ºF or fever complicated by hypotension, rigors or chills, dehydration, or renal failure, and evaluate for signs and ... Read More

2018年5月8日 — 上周五，美國FDA批准了諾華大藥廠兩大已上市的黑色素瘤藥Tafinlar及Mekinist合併療法，用於治療有BRAF基因陽性但無法手術切除或已經轉移擴散的甲狀腺 ... Read More

MEKINIST is indicated, in combination with dabrafenib, for: • the treatment of patients with unresectable or metastatic melanoma with. Read More

Dabrafenib (如Tafinlar)、Trametinib (如Mekinist)：(110/3/1). 1.Dabrafenib和trametinib併用於治療BRAF V600突變陽性ECOG≤ 2且罹患無法切除(第ⅢC期)或轉移性(第Ⅳ ... Read More

Mekinist is the trade name for the generic chemotherapy drug trametinib. In some cases, health care professionals may use the generic name trametinib when ... Read More

Mekinist 2 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd. Read More

Mekinist 0.5 mg film-coated tablets - Summary of Product Characteristics (SmPC) by Novartis Pharmaceuticals UK Ltd. Read More